Thromb Haemost 1982; 47(01): 62-65
DOI: 10.1055/s-0038-1657127
Original Article
Schattauer GmbH Stuttgart

Inhibition of Thrombin-Induced Secretion from Platelets by Chlortetracycline and Its Analogs[*]

E H Mürer
The Thrombosis Research Center, Temple University Medical School, Philadelphia, U.S.A.
,
E Siojo
The Thrombosis Research Center, Temple University Medical School, Philadelphia, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 11 May 1981

Accepted 04 January 1982

Publication Date:
13 July 2018 (online)

Preview

Summary

Chlortetracycline (CTC) (1.0 mM) blocks platelet secretion after a few seconds preincubation. The amount needed for inhibition can be reduced relative to time of preincubation. 50% inhibition is obtained with 20 ¼M CTC after 1 hr incubation. 50 ¼M CTC causes much greater inhibition, especially after short time incubation. The level of metabolic ATP is decreased about 60% with both 20 and 50 ¼M CTC. Two tetracycline analogs, anhydrotetracycline and demeclocycline (DMC), have different solubility properties in nonionic medium, but inhibit secretion at the same concentration, with little effect on the metabolic ATP level. The results suggest that CTC and its analogs do not inhibit platelet function by acting as metabolic inhibitors. While CTC causes increased leakage of cytoplasmic content at the concentrations where secretion is blocked more than 90%, DMC doses not cause leakage even at much higher concentration, so that there seems to be no connection between the induction of leakage (i.e. the membrane-active properties) and the inhibitory effect of the drugs.

* Some of these results were presented at the VII. International Congress on Thrombosis and Haemostasis, London, UK, July, 1979 (Abstract Thrombos. Haemostas. 42: 216).